Literature DB >> 30906759

Hyperphosphatemia: a novel risk factor for mortality in chronic kidney disease.

Mario Cozzolino1, Paola Ciceri1, Andrea Galassi1.   

Abstract

Entities:  

Year:  2019        PMID： 30906759      PMCID： PMC6389588          DOI： 10.21037/atm.2018.06.50

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  7 in total

Review 1.  Ambulatory Hemodialysis-Technology Landscape and Potential for Patient-Centered Treatment.

Authors:  Nina Hojs; William H Fissell; Shuvo Roy
Journal:  Clin J Am Soc Nephrol       Date:  2019-11-14       Impact factor: 8.237

2.  Investigation on maintenance hemodialysis patients with mineral and bone disorder in Anhui province, China.

Authors:  Shuman Tao; Xiuyong Li; Zhi Liu; Youwei Bai; Guangrong Qian; Han Wu; Ji Li; Yuwen Guo; Shanfei Yang; Lei Chen; Jian Yang; Jiuhuai Han; Shengyin Ma; Jing Yang; Linfei Yu; Runzhi Shui; Xiping Jin; Hongyu Wang; Fan Zhang; Tianhao Chen; Xinke Li; Xiaoying Zong; Li Liu; Jihui Fan; Wei Wang; Yong Zhang; Guangcai Shi; Deguang Wang
Journal:  Int Urol Nephrol       Date:  2022-08-11       Impact factor: 2.266

3.  Impact of Admission Calcium-phosphate Product on 1-year Mortality among Hospitalized Patients.

Authors:  Wisit Cheungpasitporn; Charat Thongprayoon; Panupong Hansrivijit; Juan Medaura; Api Chewcharat; Tarun Bathini; Michael A Mao; Stephen B Erickson
Journal:  Adv Biomed Res       Date:  2020-04-22

4.  Key genes of renal tubular necrosis: a bioinformatics analysis.

Authors:  Peng Lin; Yongqing Pan; Hang Chen; Ling Jiang; Yunhua Liao
Journal:  Transl Androl Urol       Date:  2020-04

5.  Phosphate clearance in peritoneal dialysis.

Authors:  Malgorzata Debowska; Rafael Gomez; Joyce Pinto; Jacek Waniewski; Bengt Lindholm
Journal:  Sci Rep       Date:  2020-10-15       Impact factor: 4.379

6.  Mineral and bone disorder and longterm survival in a chronic kidney disease grade 3b-4cohort.

Authors:  Pablo Rios; Ricardo Silvariño; Laura Sola; Alejandro Ferreiro; Verónica Lamadrid; Laura Fajardo; Liliana Gadola
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

7.  Investigation of nicotinamide as more than an anti-phosphorus drug in chronic hemodialysis patients: a single-center, double-blind, randomized, placebo-controlled trial.

Authors:  Xiang-Yang Liu; Jing-Rui Yao; Rong Xu; Lin-Xin Xu; Yue-Feng Zhang; Shan Lu; Zhi-Heng Xing; Li-Ping Fan; Zhong-Hua Qin; Bei Sun
Journal:  Ann Transl Med       Date:  2020-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.